phenoxybenzamine has been researched along with cardiovascular agents in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clarke, D; Jacobson, LO; Lee, C; Smith, WL; Strosberg, AM | 1 |
Jarboe, CH; Teller, SR | 1 |
Davies, MG; Hagen, PO; Huynh, TT | 1 |
FORD, RV; MILLER, SI; MOYER, JH | 1 |
GROLLMAN, A; SHAPIRO, AP | 1 |
LANSING, AM; LEWIS, RA; WAUD, RA | 1 |
FOWLER, FD; MOSER, M | 1 |
DANIELL, HW | 1 |
8 other study(ies) available for phenoxybenzamine and cardiovascular agents
Article | Year |
---|---|
Effects of RS-59022-198 on the uptake and release of norepinephrine in isolated rat hearts.
Topics: Animals; Cardiovascular Agents; Heart; In Vitro Techniques; Male; Myocardium; Neurons; Norepinephrine; Phenoxybenzamine; Pyrrolidines; Rats; Rats, Inbred Strains | 1992 |
Synthesis and peripheral cardiovascular action of cis- and trans-2-(3,4-dimethoxybenzyl)cyclopentylamine hydrochlorides.
Topics: Animals; Blood Pressure; Cardiovascular Agents; Chemical Phenomena; Chemistry; Cimetidine; Cyclopentanes; Dogs; Dopamine; Drug Interactions; Female; Male; Methysergide; Metoclopramide; Phenoxybenzamine; Stereoisomerism | 1982 |
Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Topics: Adjuvants, Immunologic; Adrenergic alpha-Antagonists; Animals; Cardiotonic Agents; Cardiovascular Agents; Carotid Artery, Common; Cholera Toxin; Dopamine; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Graft Occlusion, Vascular; GTP-Binding Proteins; Hyperplasia; Indomethacin; Jugular Veins; Male; Nitric Oxide; omega-N-Methylarginine; Phenoxybenzamine; Prostaglandins; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tunica Intima; Vasodilation | 2000 |
Dibenzyline: results of therapy in patients with hypertension and a comparison with hexamethonium, 1-hydrazinophthalazine and semipurified extracts of veratrum.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Muscle Relaxants, Central; Phenoxybenzamine; Sympatholytics; Veratrum; Veratrum Alkaloids | 1953 |
A critical evaluation of the hypotensive asction of hydrallazine, hexamethonium, tetraethylammonium and dibenzyline salts in human and experimental hypertension.
Topics: Cardiovascular Agents; Hexamethonium; Hydralazine; Hypertension; Hypotension; Muscle Relaxants, Central; Phenoxybenzamine; Salts; Sympatholytics; Tetraethylammonium | 1953 |
The effects of veratrum, dibenzyline and hexamethonium on blood pressure as studied with an artificial heart-lung.
Topics: Blood Pressure; Cardiovascular Agents; Heart, Artificial; Hexamethonium; Muscle Relaxants, Central; Phenoxybenzamine; Sympatholytics; Veratrum; Veratrum Alkaloids | 1955 |
Use of hexamethonium and dibenzyline in diagnosis and treatment of causalgia.
Topics: Cardiovascular Agents; Causalgia; Hexamethonium; Muscle Relaxants, Central; Neuralgia; Phenoxybenzamine; Sympatholytics | 1956 |
VASOSPASTIC REACTION TO METHYSERGIDE MALEATE SIMULATING LERICHE SYNDROME: INEFFECTIVE TREATMENT WITH ADRENERGIC BLOCKADE.
Topics: Adrenergic Agents; Cardiovascular Agents; Diagnosis, Differential; Drug Therapy; Erectile Dysfunction; Ergot Alkaloids; Headache; Hip; Humans; Leriche Syndrome; Male; Methysergide; Oscillometry; Phenoxybenzamine; Phentolamine; Physical Exertion; Tolazoline; Toxicology | 1964 |